Clinical trials
Pulmonary Embolism clinical trials
Below are recruiting pulmonary embolism clinical trials, each written for real people, not researchers. We’re tracking 103 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04355975Recruiting
Study follow-up outcomes after a lung blood clot
This trial looks at how people do after an acute pulmonary embolism (a blood clot in the lungs). It aims to understand real-world outcomes over follow-up and may help improve how care teams track patients after treatment.
Bern, Canton of BernAges Any age - NCT07814118Enrolling by invitation
Understanding how your body works during routine care
This study looks at how different body systems work together in people with various conditions and healthy volunteers. It uses routine medical tests and data to understand health better, which can help improve future care.
New York, New YorkAges 18 years+ - NCT07805616Recruiting
New risk categories for blood clots in the lungs
This study looks at whether a new way of grouping patients with blood clots in the lungs (pulmonary embolism) can better predict their outcomes. If you join, your health will be tracked for 30 days to see how well this new system works.
IstanbulAges 18 years+ - NCT07724197Recruiting
Using a new imaging test to find blood clots in the lungs
This study tests a new, non-invasive imaging method called pulsatile electrical impedance tomography (EIT) to help diagnose and monitor acute pulmonary embolism (blood clots in the lungs). It may provide a faster or safer way to detect clots compared to standard CT scans, especially for patients who cannot have contrast dye.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07650435Recruiting
Clot removal in pulmonary embolism trial
This study tests a procedure to remove blood clots from the lungs in people with moderate or severe pulmonary embolism. It may help reduce strain on the heart and improve recovery.
PlymouthAges 18 years+ - NCT07647497Recruiting
Heart Imaging to Predict Outcomes in Pulmonary Embolism
This study uses ultrasound images of your heart to see how well the right side is working in people who have a blood clot in the lungs. The goal is to better predict which patients might be at higher risk and need more intensive care.
SohagAges 18 years+ - NCT07527117Recruiting
CT scan study for diagnosing sudden blood clots in lungs
This research study tests a special chest CT scan to help diagnose acute pulmonary embolism—a blood clot that suddenly blocks blood flow in your lungs. You may qualify if you're already getting a CT scan for suspected lung clots and meet basic health requirements.
Boston, MassachusettsAges 21 years+ - NCT07491094Recruiting
Repeated exams for pulmonary embolism follow-up
This study looks at repeated scans and tests for people who have had a pulmonary embolism (PE) — a blood clot in the lungs. It aims to improve how doctors monitor recovery and decide on treatment.
Gothenburg, Region Västra GötalandAges 18 years+ - NCT07436702Recruiting
Best time for treatment in serious pulmonary embolism
This trial looks at when it's best to give treatment to restore blood flow in people with a serious type of pulmonary embolism. It aims to find the optimal time for this procedure to improve outcomes.
Milan, MilanoAges 18 years+ - NCT07431229Recruiting
Nitrates for moderate-to-high risk pulmonary embolism
This trial tests whether a common food additive (nitrates) can help your heart recover faster when you have a serious pulmonary embolism. It is for people with a recent clot and signs of heart strain, but who are not on specific blood thinners or other nitrate medicines.
StockholmAges 18 years+ - NCT06528418Recruiting
Breath test to find lung diseases
This study uses a simple breath test to detect different lung diseases. By analyzing the chemicals in your breath, researchers hope to find a faster, non-invasive way to diagnose lung conditions. It may be an option if you have a known lung disease and have a recent CT scan.
Guangzhou, GuangdongAges 18–100 - NCT07245927Recruiting
Staphylokinase for massive pulmonary embolism with shock
This trial tests a single injection of a clot-busting drug called staphylokinase for people with a massive pulmonary embolism that is causing shock or very low blood pressure. It aims to see how well the drug works in this emergency situation.
BelgorodAges 18 years+ - NCT07190079Recruiting
New way to diagnose blood clots in the lungs using saline
This study tests a new method using a saline solution and a special imaging belt to quickly diagnose pulmonary embolism (a blood clot in the lungs) in people with acute breathing problems. If successful, it could provide a faster, safer alternative to standard CT scans.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06946732Recruiting
Acostream for high-risk and intermediate-risk pulmonary embolism
This trial is testing a device (called the Acostream) to break up blood clots in the lungs for people with serious pulmonary embolism who cannot receive standard clot-busting drugs or surgery. It may be an option if you have high-risk or intermediate-risk PE and are between 18 and 85.
Shanghai, Shanghai MunicipalityAges 18–85 - NCT04711746Recruiting
Clonal blood changes after certain lung blood clots
This study looks at whether a specific kind of blood-cell change (“clonal hematopoiesis”) is linked to a lung blood clot (pulmonary embolism) that happened without a clear trigger. It compares people with unprovoked clots to people with provoked clots, after checking for inherited clotting risk factors.
AmiensAges 18–65 - NCT07029841Recruiting
Catheter therapy study for acute pulmonary embolism patients
This study follows patients in Hong Kong who are treated with catheter-based therapy for acute pulmonary embolism. It aims to understand how well this treatment works.
Hong Kong, Hong KongAges 18 years+ - NCT07003646Recruiting
Treating acute pulmonary embolism with clot-dissolving or catheter procedures
This study looks at how well different treatments work for a blood clot in the lung (pulmonary embolism). It includes people who are getting or have already gotten a clot-dissolving medicine or a catheter procedure to remove the clot.
AarhusAges 18 years+ - NCT06912009Recruiting
How long to treat blood clots in the lungs
This trial looks at how long people need blood-thinning medicine after a serious blood clot in the lungs. It might help doctors find the best treatment length for each person.
StrasbourgAges 18 years+ - NCT06697314Recruiting
Clot removal for acute pulmonary embolism with heart strain
This study tests a new device (AlphaVac) that removes blood clots from the lungs using a thin tube inserted through a vein. It may be an option for people with acute pulmonary embolism who have signs of heart strain or low blood pressure.
PoznanAges 18 years+ - NCT06672081Recruiting
Early catheter treatment for high-risk pulmonary embolism
This study tests whether using a catheter (a thin tube) to remove blood clots from the lungs early can help people with a severe, life-threatening pulmonary embolism. It is for patients who are in shock or have had a cardiac arrest due to a large clot.
Bad KrozingenAges 18 years+ - NCT06433011Recruiting
New clot-busting method for pulmonary embolism
This study tests a new way of delivering a clot-dissolving medicine for people with a serious but not immediately life-threatening pulmonary embolism. The goal is to see if giving the medicine as small bursts directly into the clot can help the heart recover faster.
Scottsdale, ArizonaAges Any age - NCT06362746RecruitingPhase 3
Staphylokinase for intermediate high-risk pulmonary embolism
This trial tests a new drug, staphylokinase, to see if it can break up blood clots in the lungs in people with a moderate-high risk pulmonary embolism. The goal is to improve blood flow and reduce the chance of complications.
Barnaul, Altayskiy KrayAges 18 years+ - NCT06348459Recruiting
Catheter treatment for severe pulmonary embolism
This study looks at how well a catheter (a thin tube) works to treat a serious type of blood clot in the lungs. It is for people who have a large clot that is causing problems like fast heart rate or low blood pressure.
Madrid, MadridAges 18 years+ - NCT06166329Recruiting
Chair lift test for pulmonary embolism prognosis
This study checks if a simple chair lift test can help predict recovery in patients with a blood clot in the lung (pulmonary embolism) who are not critically ill. It aims to find out if this test can help doctors decide on the best follow-up care.
RouenAges 18 years+
Hear when a new Pulmonary Embolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Pulmonary Embolism trials by city
Studies with a site in or near these metro areas.
Pulmonary Embolism trials by state
Studies with a site anywhere in these states.
Common questions
- Are there clinical trials for pulmonary embolism?
- Yes. Clin2 currently lists 103 recruiting pulmonary embolism studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pulmonary embolism trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pulmonary embolism trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.